Business Description
LigaChem Biosciences Inc
ISIN : KR7141080002
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 41.82 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.95 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 24.67 | |||||
Beneish M-Score | -1.49 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -17.9 | |||||
3-Year EBITDA Growth Rate | -28.3 | |||||
3-Year EPS without NRI Growth Rate | -101.4 | |||||
3-Year FCF Growth Rate | -41.8 | |||||
3-Year Book Growth Rate | 3.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 85.94 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.64 | |||||
9-Day RSI | 50.09 | |||||
14-Day RSI | 48.06 | |||||
6-1 Month Momentum % | 32.82 | |||||
12-1 Month Momentum % | 83.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.81 | |||||
Quick Ratio | 6.81 | |||||
Cash Ratio | 6.42 | |||||
Days Inventory | 5.09 | |||||
Days Sales Outstanding | 47.52 | |||||
Days Payable | 161.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.7 | |||||
Shareholder Yield % | -13.36 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 84.38 | |||||
Operating Margin % | -31.95 | |||||
Net Margin % | -2.89 | |||||
FCF Margin % | 42.64 | |||||
ROE % | -0.67 | |||||
ROA % | -0.56 | |||||
ROIC % | -13.39 | |||||
ROC (Joel Greenblatt) % | -66.85 | |||||
ROCE % | -4.09 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 67.8 | |||||
Price-to-Owner-Earnings | 77.67 | |||||
PS Ratio | 30.9 | |||||
PB Ratio | 5.9 | |||||
Price-to-Tangible-Book | 5.97 | |||||
Price-to-Free-Cash-Flow | 60.05 | |||||
Price-to-Operating-Cash-Flow | 56.39 | |||||
EV-to-EBIT | -177.96 | |||||
EV-to-EBITDA | -244.19 | |||||
EV-to-Revenue | 32.01 | |||||
EV-to-FCF | 70 | |||||
Price-to-Projected-FCF | 9.3 | |||||
Price-to-Median-PS-Value | 1.12 | |||||
Price-to-Net-Current-Asset-Value | 7.96 | |||||
Price-to-Net-Cash | 8.55 | |||||
Earnings Yield (Greenblatt) % | -0.56 | |||||
FCF Yield % | 1.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
LigaChem Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 101,417.074 | ||
EPS (TTM) (â‚©) | -29 | ||
Beta | 1.06 | ||
Volatility % | 78.61 | ||
14-Day RSI | 48.06 | ||
14-Day ATR (â‚©) | 6962.558289 | ||
20-Day SMA (â‚©) | 102850 | ||
12-1 Month Momentum % | 83.65 | ||
52-Week Range (â‚©) | 46350 - 143600 | ||
Shares Outstanding (Mil) | 36.43 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
LigaChem Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
LigaChem Biosciences Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
LigaChem Biosciences Inc Frequently Asked Questions
What is LigaChem Biosciences Inc(XKRX:141080)'s stock price today?
When is next earnings date of LigaChem Biosciences Inc(XKRX:141080)?
Does LigaChem Biosciences Inc(XKRX:141080) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |